References
- Morgenthaler T.I., Brown L.R., Colby T.V., Harper C.M., Jr., Coles D.T. Thymoma. Mayo Clin. Proc. 1993; 68: 110–1123
- Soudajian J.V., Enriquez P., Silverstein M.N., Pepin J.M. The spectrum of diseases associated with thymoma. Coincidence or syndrome?. Arch. Intern. Med. 1974; 134: 374–379
- Kohman L.J. Controversies in the management of malignant thymoma. Chest 1997; 112: 296–300
- Maggi G., Giaccione G., Donadio M., et al. Thymomas: a review of 169 cases, with particular reference to results of surgical treatment. Cancer 1986; 58: 765–776
- Regnard J.F., Magdeleinat P., Dromer C., Dulmet E., de Montpreville V., Levi J.F., Levasseur P. Prognostic factors and long-term results after thymoma resection: a series of 307 patients. J. Thorac. Cardiovasc. Surg. 1996; 112: 376–384
- Blumberg D., Port J.L., Weksler B., Delgado R., Rosai J., Bains M.S., Ginsberg R.J., Martini N., McCormack P.M., Rusch V. Thymoma: a multivariate analysis of factors predicting survival. Ann. Thorac. Surg. 1995; 60: 908–914
- Gripp S., Hilgers K., Wurm R., Schmitt G. Thymoma: prognostic factors and treatment outcomes. Cancer 1998; 83: 1495–1503
- Lara P.N., Jr. Malignant thymoma: current status and future directions. Cancer Treat. Rev. 2000; 26: 127–131
- Komaki R., Putnam J.B., Jr., Shin D.M., Cox J.D. Thymic neoplasms. Curr. Opin. Oncol. 1997; 9: 156–160
- Gonzales-Gonzales D. The need for prospective clinical studies in thymomas (Editorial). Radiother. Oncol. 1991; 21: 75–76
- Masaoka A., Monden Y., Nakahara K., Tanioka T. Follow-up study of thymomas with special reference to their clinical stages. Cancer 1981; 48: 2485–2492
- McCart J.A., Gaspar L., Inculet R., Casson A.G. Predictors of survival following surgical resection of thymoma. J. Surg. Oncol. 1993; 54: 233–238
- Wilkins E.W., Grillo H.C., Scannell J.G., Moncure A.C., Mathisen D.J. Role of staging in prognosis and management of thymoma. Ann. Thorac. Surg. 1991; 51: 888–892
- Ciernik I.F., Meier U., Lütolf U.M. Prognostic factors and outcome of incompletely resected invasive thymoma following radiation therapy. J. Clin. Oncol. 1994; 12: 1484–1490
- Cowen D., Richaud P., Mornex F., Bachelot T., Jung G.M., Mirabel X., Marchal C., Lagrange J.L., Rambert P., Chaplain G. Thymoma: results of a multicentric retrospective series of 149 non-metastatic irradiated patients and review of literatute. FNCLCC Trialists. Radiother. Oncol. 1995; 34: 9–16
- Ruffini E., Mancuso M., Oliaro A., Casadio C., Cavallo A., Cianci R., Filosso P.L., Molinatti M., Porrello C., Cappello N., Maggi G. Recurrence of thymoma: analysis of clinicopathologic features, treatment, and outcome. J. Thorac. Cardiovasc. Surg. 1997; 113(1)55–63
- Wang L.S., Huang M.H., Lin T.S., Huang B.S., Chien K.Y. Malignant thymoma. Cancer 1992; 70(2)443–450
- Sassa K., Mizushima Y., Kusajima Y., Sugiyama S., Noto H., Kobayashi M. Clinical study on thymoma: assessment of prognostic factors. Anticancer Res. 1996; 16(6B)3895–3900
- Wilkins K.B., Sheikh E., Green R., Patel M., George S., Takano M., Diener-West M., Welsh J., Howard S., Askin F., Bulkley G.B. Clinical and pathologic predictors of survival in patients with thymoma. Ann. Surg. 1999; 230(4)562–572
- Jaretzki A., Wollf M. “Maximal” thymectomy for myastenia gravis: surgical anatomy and operative technique. J. Thorac. Cardiovasc. Surg. 1988; 96: 711–716
- Batata M.A., Martini N., Huvos A.G., Aguilar R.I., Beattie E.J., Jr. Thymomas: clinicopathologic features, therapy and prognosis. Cancer 1974; 34: 389–396
- Uematsu M., Yoshida H., Kondo M., Itami J., Hatano K., Isobe K., Ito H., Kobayashi K., Yamaguchi Y., Kubo A. Entire hemithorax irradiation following complete resection in patients with stage II–III invasive thymoma. Int. J. Radiat. Oncol. Biol. Phys. 1996; 35: 357–360
- Bjerrum O.W., Kiss K., Daugaard G. Combination chemotherapy with a five-drug regimen for invasive thymoma. Acta Oncol. 1996; 35(1)71–73
- Goldel N., Boning L., Fredrik A., Holzel D., Hartenstein R., Wilmanns W. Chemotherapy of invasive thymoma. A retrospective study of 22 cases. Cancer 1989; 63(8)1493–1500
- Loehrer P.J., Sr., Chen M., Kim K., Aisner S.C., Einhorn L.H., Livingston R., Johnson D. Cisplatin, doxorubicin, and cyclophosphamide plus thoracic radiation therapy for limited-stage unresectable thymoma: an intergroup trial. J. Clin. Oncol. 1997; 15(9)3093–3099